LIN28B and breast carcinoma: As is the case for NFκB, the activation of STAT3 in breast cancer promotes the transcription of Lin28B by directly binding to the Lin28B promoter, resulting in the repression of let-7 expression and concomitant upregulation of the let-7 target, HMGA2 [95].